Journal
ACTA CYTOLOGICA
Volume 54, Issue 1, Pages 55-59Publisher
KARGER
DOI: 10.1159/000324967
Keywords
CD63; CD56; immunohistochemistry; lung cancer; p63
Categories
Ask authors/readers for more resources
Objective To determine whether CD63, p63 and CD56, are useful in the diagnostic evaluation of cytologic samples of pulmonary malignancy. Study Design We explored the utility of using a panel of 13 antibodies, CD63, p63 and CD56, for the diagnosis of lung cancer in cytologic samples consisting of 40 cases of cell block sections and previously Papanicolaou-stained cytologic smear slides. Results The positive rates for CD63, p63 and CD56 were as follows: adenocarcinoma (18/19), (0/19) (0/19) for small cell lung carCinowa (3/8), (0/8), (8/8), and for squamous cell carcinoma (0/13), (12/13), (0/13). All p63 positive cases were squamous cell carcinoma, and all CD56 positive cases were small cell lung carcinoma. CD63 was positive in the majority of adenocarcinomas. Conclusion The panel of CD63, p63 and CD56 appears to be useful in the diagnostic evaluation of cytologic samples of pulmonary malignancy. (Acta Cytol 2010;54:55-59)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available